On the recordMarch 27, 2023
Shining a light on middlemen who are making prescriptions more expensive is one important step to bolster competition.
Source
congress.govEditor's note · Context
Guthrie advocates for transparency regarding middlemen in the prescription drug market.
Share & report
More from James Guthrie
Dec 1, 2021
I am really frustrated that we failed to come up with and join together to permanently schedule fentanyl analogs.
Apr 25, 2023
There is also bipartisan legislation from Representative Carter that would finally ban spread pricing in Medicaid.
Dec 1, 2021
I will continue to press permanently scheduling fentanyl analogs and giving law enforcement the resources needed to fight back against the illicit trafficking of fentanyl.
Mar 28, 2023
There is no reason why we should continue to see Americans paying 2 to 3 times more for drugs here in America, when those same drugs are sold in other parts of the world for so much less.
Other voices in this conversation
